EUCTR2004-001033-41-IT进行中（未招募）不适用
A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erectile dysfunction
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ELI LILLY
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Randomized, Double-Blind, Parallel Design, Repeat Dose, 2-arm, Multicenter Study Comparing the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profiles of AVT03 and US-Prolia® in Postmenopausal Women with Osteoporosis, ALVOBONDMedDRA version: 20.0Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2021-005071-40-CZAlvotech Swiss AG532
已完成
4 期
TO EVALUATE THE SAFETY AND EFFICACY OF BISMOZYME IN PATIENTS GASTROINTESTINAL MOTILITY DISORDERCTRI/2020/08/027027Eastern Drug
进行中（未招募）
1 期
A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with Severe Asthma Inadequately Controlled with Standard of Care.Severe and inadequately controlled asthmaMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-001520-34-ITASTRAZENECA AB2,800
招募中
1 期
A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with Severe Asthma Inadequately Controlled with Standard of Care.Severe and inadequately controlled asthmaMedDRA version: 20.0Level: PTClassification code: 10003553Term: Asthma Class: 100000004855MedDRA version: 20.0Level: SOCClassification code: 10038738Term: Respiratory thoracic and mediastinal disorders Class: 13CTIS2023-505787-11-00AstraZeneca AB1,557
进行中（未招募）
1 期
A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with Severe Asthma Inadequately Controlled with Standard of Care.EUCTR2020-001520-34-HUAstraZeneca AB2,200